These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 14564229

  • 1. New concepts in post-infarction ventricular remodeling.
    Udelson JE, Patten RD, Konstam MA.
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S3-12. PubMed ID: 14564229
    [Abstract] [Full Text] [Related]

  • 2. Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.
    Udelson JE, Konstam MA.
    J Card Fail; 2002 Dec; 8(6 Suppl):S465-71. PubMed ID: 12555159
    [Abstract] [Full Text] [Related]

  • 3. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD, Udelson JE, Konstam MA.
    Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
    [Abstract] [Full Text] [Related]

  • 4. Ventricular remodeling in heart failure and the effect of beta-blockade.
    Udelson JE.
    Am J Cardiol; 2004 May 06; 93(9A):43B-8B. PubMed ID: 15144937
    [Abstract] [Full Text] [Related]

  • 5. Effects of angiotensin converting enzyme inhibitors on remodeling in clinical trials.
    Greenberg BH.
    J Card Fail; 2002 Dec 06; 8(6 Suppl):S486-90. PubMed ID: 12555162
    [Abstract] [Full Text] [Related]

  • 6. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR.
    J Card Fail; 2000 Jun 06; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [Abstract] [Full Text] [Related]

  • 7. Left ventricular remodeling: pathophysiology and treatment.
    Sharpe N.
    Heart Fail Monit; 2003 Jun 06; 4(2):55-61. PubMed ID: 14724719
    [Abstract] [Full Text] [Related]

  • 8. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U, Wollert KC, Drexler H.
    Cardiovasc Res; 2009 Feb 15; 81(3):519-27. PubMed ID: 19019834
    [Abstract] [Full Text] [Related]

  • 9. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X, Saini HK, Wang J, Gupta SK, Goyal RK, Dhalla NS.
    Expert Rev Cardiovasc Ther; 2005 Jul 15; 3(4):717-32. PubMed ID: 16076281
    [Abstract] [Full Text] [Related]

  • 10. Drugs for left ventricular remodeling in heart failure.
    Frigerio M, Roubina E.
    Am J Cardiol; 2005 Dec 19; 96(12A):10L-18L. PubMed ID: 16399088
    [Abstract] [Full Text] [Related]

  • 11. Ventricular remodeling in heart failure.
    Gaballa MA, Goldman S.
    J Card Fail; 2002 Dec 19; 8(6 Suppl):S476-85. PubMed ID: 12555161
    [Abstract] [Full Text] [Related]

  • 12. Natural history of end-stage LV dysfunction: has it improved from the classic Franciosa and Cohn Graph?
    Jacoby D, Albajrami O, Bellumkonda L.
    Cardiol Clin; 2011 Nov 19; 29(4):485-95. PubMed ID: 22062195
    [Abstract] [Full Text] [Related]

  • 13. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
    Khattar RS.
    Minerva Cardioangiol; 2003 Apr 19; 51(2):143-54. PubMed ID: 12783070
    [Abstract] [Full Text] [Related]

  • 14. Treatments that improve outcome in the patient with heart failure, left ventricular systolic dysfunction, or both after acute myocardial infarction.
    Weir R, McMurray JJ.
    Heart; 2005 May 19; 91 Suppl 2(Suppl 2):ii17-20; discussion ii31, ii43-8. PubMed ID: 15831602
    [Abstract] [Full Text] [Related]

  • 15. Strategies to attenuate pathological remodeling in heart failure.
    Eapen Z, Rogers JG.
    Curr Opin Cardiol; 2009 May 19; 24(3):223-9. PubMed ID: 19318933
    [Abstract] [Full Text] [Related]

  • 16. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators.
    Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606
    [Abstract] [Full Text] [Related]

  • 17. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
    McMurray JJ, Pfeffer MA, Swedberg K, Dzau VJ.
    Circulation; 2004 Nov 16; 110(20):3281-8. PubMed ID: 15545527
    [No Abstract] [Full Text] [Related]

  • 18. The dog model of left ventricular remodeling after myocardial infarction.
    Jugdutt BI.
    J Card Fail; 2002 Dec 16; 8(6 Suppl):S472-5. PubMed ID: 12555160
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.